Results 191 to 194 of about 1,991 (194)
Some of the next articles are maybe not open access.
Mavacamten (â–¼Camzyos) for obstructive hypertrophic cardiomyopathy
Drug and Therapeutics Bulletinopenaire +1 more source
PLN-related obstructive hypertrophic cardiomyopathy responsive to mavacamten
European Heart JournalMatteo Beltrami +2 more
openaire +2 more sources
Mavacamten - Erster Wirkstoff gegen obstruktive hypertrophe Kardiomyopathie
Österreichische Apothekerzeitung, 2023openaire +1 more source

